Stamaril yellow fever
Selected indexed studies
- Yellow Fever Vaccine. (, 2006) [PMID:30000198]
- Safety profile of the yellow fever vaccine Stamaril®: a 17-year review. (Expert Rev Vaccines, 2013) [PMID:24066727]
- Enhanced safety surveillance of STAMARIL® yellow fever vaccine provided under the expanded access investigational new drug program in the USA. (J Travel Med, 2023) [PMID:37000007]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Vaccines for travelers. (2018) pubmed
- Yellow Fever Vaccine. (2006) pubmed
- Safety profile of the yellow fever vaccine Stamaril®: a 17-year review. (2013) pubmed
- Enhanced safety surveillance of STAMARIL® yellow fever vaccine provided under the expanded access investigational new drug program in the USA. (2023) pubmed
- Yellow fever vaccine: comparison of the neurovirulence of new 17D-204 Stamaril™ seed lots and RK 168-73 strain. (2013) pubmed
- Limited evolution of the yellow fever virus 17d in a mouse infection model. (2019) pubmed
- Next generation live-attenuated yellow fever vaccine candidate: Safety and immuno-efficacy in small animal models. (2021) pubmed
- Real-world evidence of yellow Fever vaccination data-driven study. (2025) pubmed
- Immunogenicity and Safety of Yellow Fever Vaccine (Stamaril) When Administered Concomitantly With a Tetravalent Dengue Vaccine Candidate in Healthy Toddlers at 12-13 Months of Age in Colombia and Peru: A Randomized Trial. (2016) pubmed
- Bis(Benzofuran-1,3-N,N-heterocycle)s as Symmetric and Synthetic Drug Leads against Yellow Fever Virus. (2022) pubmed